Anthem INC (ANTM) Stake Decreased by Loews Corp

June 29, 2018 - By Eric Painter

Anthem, Inc. (NYSE:ANTM) Corporate Logo

In Anthem Inc (ANTM) was reduced the holdings owned by Loews Corp. The decrease is 85.96% according to 2018Q1 SEC form. The company’s stock sank 2.45% while Loews Corp sold 14,700 shares. The health care company announced $527,000 value for the 2018Q1. Now the institutional investor is holding 2,400 shares, compared to the 17,100 from the previous quarter. $61.54 billion is Anthem Inc’s market cap. The stock increased 0.79% or $1.88 during the last trading session, touching $241.15.Anthem, Inc. has volume of 349,333 shares. Since June 29, 2017 ANTM has risen 28.04% and is uptrending. ANTM outperformed by 15.47% the S&P 500.

About $14.93 billion US Long portfolio Loews Corp operates. According to a filing the fund increased its stake in Aetna Inc (NYSE:AET) by 34,000 shares to 189,600 shares, valued at $32.04 million in 2018Q1. For a total of 500,000 shares it increased its holding in Myers Industries Inc (NYSE:MYE) by 183,772 shares in the quarter, and has risen its stake in Dowdupont Inc.

On July, 25 is anticipated Anthem, Inc. (NYSE:ANTM)’s earnings report, RTT reports. This year’s earnings per share analyst estimate is anticipated to be $4.16. That is 23.44 % up compareed to $3.37 earnings per share for last year. If earnings per share of $4.16 is published the profit of ANTM could hit $1.06 billion giving it 14.49 P/E. After $5.41 EPS report previous quarter, Wall Street now sees -23.11 % negative EPS growth of Anthem, Inc..

For more Anthem, Inc. (NYSE:ANTM) news posted recently go to:,,, or The titles are as follows: “Market Trends Toward New Normal in Cheniere Energy Partners, LP, UnitedHealth Group, Anthem, Sage Therapeutics …” posted on June 12, 2018, “Castlight Health Has $10B Potential Market, William Blair Says In Bullish Initiation” on June 20, 2018, “Blue Cross of MN names Anthem exec CEO” with a publish date: June 28, 2018, “Anthem, Inc. Completes Acquisition of Aspire Health” and the last “6 Top Healthcare Trends You Can’t Afford to Ignore” with publication date: June 27, 2018.

Anthem, Inc. (NYSE:ANTM) Ratings Coverage

In total 15 analysts cover Anthem (NYSE:ANTM). “Buy” rating has 13, “Sell” are 0, while 2 are “Hold”. 87% are bullish. 20 are the (NYSE:ANTM)’s analyst reports since January 3, 2018 according to StockzIntelligence Inc. On Thursday, January 25 the firm earned “Buy” rating by Bernstein. The stock rating was maintained by Wells Fargo with “Outperform” on Thursday, February 1. On Wednesday, January 31 the rating was maintained by Jefferies with “Buy”. On Thursday, January 18 the stock has “Buy” rating by Cantor Fitzgerald. On Wednesday, January 31 the rating was maintained by Cowen & Co with “Buy”. On Thursday, February 1 the stock of Anthem, Inc. (NYSE:ANTM) has “Buy” rating given by RBC Capital Markets. On Wednesday, January 3 the rating was upgraded by PiperJaffray to “Overweight”. On Thursday, April 26 the company was upgraded by J.P. Morgan. The stock rating was maintained by Credit Suisse with “Outperform” on Thursday, April 26. In Wednesday, January 3 report Goldman Sachs initiated it with “Hold” rating and $243.0 target.

Anthem, Inc. (NYSE:ANTM) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.